Janos L. Tanyi

Oncology

3400 Civic Center Boulevard
West Pavilion, 3rd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer.

PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer.

Journal: The Journal of clinical investigation

Published: July 07, 2026

Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.

Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.

Journal: eLife

Published: February 03, 2026

Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers.

Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 12, 2025

Pembrolizumab-associated Guillain-Barre syndrome in a patient with endometrial cancer: A case report.

Pembrolizumab-associated Guillain-Barre syndrome in a patient with endometrial cancer: A case report.

Journal: Gynecologic oncology reports

Published: June 03, 2025

The Sensitivity and Specificity of Total Prostate Specific Antigen in the Diagnosis of Prostate Cancer in a Resource-Limited African Setting: A 5-Year Review in a Kenyan Hospital.

The Sensitivity and Specificity of Total Prostate Specific Antigen in the Diagnosis of Prostate Cancer in a Resource-Limited African Setting: A 5-Year Review in a Kenyan Hospital.

Journal: Clinical genitourinary cancer

Published: March 17, 2025

Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populations.

Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populations.

Journal: Cell reports

Published: March 04, 2025

Detection of Human Papillomavirus DNA on Red Blood Cells in Patients With Cervical Cancer.

Detection of Human Papillomavirus DNA on Red Blood Cells in Patients With Cervical Cancer.

Journal: Obstetrics and gynecology

Published: December 02, 2024

Giant Angiomyofibroblastoma With a Florid Lipomatous Component: A Report and Review of Diagnostic Considerations.

Giant Angiomyofibroblastoma With a Florid Lipomatous Component: A Report and Review of Diagnostic Considerations.

Journal: International journal of surgical pathology

Published: November 20, 2024

Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer.

Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer.

Journal: Cell reports. Medicine

Published: November 15, 2024

LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

Journal: NPJ precision oncology

Published: June 14, 2024

Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.

Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.

Journal: bioRxiv : the preprint server for biology

Published: June 03, 2024

Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer.

Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer.

Journal: Cancer cell

Published: May 07, 2024

Showing 1-12 of 91

Last Updated: 09/26/2026